Consecutive open-market sales by both the CEO and CFO raise concerns about insider confidence, particularly when combined with sales by other key individuals. Traders should monitor upcoming earnings disclosures or corporate updates for potential negative catalysts.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 23 $18.89entry
- T+1 · 9mo ago +1.11%α +0.38% · $19.10
- T+5 · 9mo ago +22.50%α +21.88% · $23.14
- T+20 · 8mo ago +1.32%α +5.27% · $19.14
- T+60 · 6mo ago +13.55%α +5.30% · $21.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four insiders at 10x Genomics sold shares in the past week, including CEO Serge Saxonov and CFO Adam Taich, with total open-market sales amounting to approximately $638,000. All transactions were direct sales at market prices, with no non-cash or derivative-related activity.
Key Financial Metrics
Key Facts
- CEO Serge Saxonov sold 9,632 shares for $178,928 in open-market transactions.
- CFO Adam Taich sold 8,968 shares for $166,593, also in open-market sales.
- Two other insiders, Benjamin J. Hindson and Sarah A. Teichmann, sold a combined $312,587 worth of shares.
- Total insider sales over the 7-day window: ~$638,000 in open-market transactions.
- All sales occurred at prices between $18.58 and $19.41 per share.
Financial Impact
$638,000 in total insider selling over 7 days, representing 0.023% of the company's $2.8B market cap
Risk Factors
- Insider selling may signal lack of confidence in near-term prospects.
- Potential for negative market sentiment despite relatively small dollar volume relative to market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (4 trades, 7d window) | cluster-TXG-1772226129892 |
Track record
28 reports on TXG
1 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers